{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06361836",
            "orgStudyIdInfo": {
                "id": "SBT777101-02"
            },
            "organization": {
                "fullName": "Sonoma Biotherapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa",
            "officialTitle": "A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Hidradenitis Suppurativa",
            "acronym": "Regulate-HS",
            "therapeuticArea": [
                "Other"
            ],
            "study": "study-of-single-doses-of-in-subjects-with-hidradenitis-suppurativa"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-08",
            "studyFirstSubmitQcDate": "2024-04-08",
            "studyFirstPostDateStruct": {
                "date": "2024-04-12",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Sonoma Biotherapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will test the safety and effects of SBT777101 when given as a single dose to subjects with hidradenitis suppurativa. Increasing dose levels will be given after the safety at lower dose levels is shown.",
            "detailedDescription": "The study evaluates the safety and effects of a novel regulatory CARTreg cell-based autoimmune and inflammatory disease therapy for the treatment of hidradenitis suppurativa. The therapy is an autologous (using the patient's own cells) Treg cell therapy that targets proteins in the inflamed, disease-associated tissue, with the aim to dampen inflammation and restore balance to the immune system."
        },
        "conditionsModule": {
            "conditions": [
                "Hidradenitis Suppurativa"
            ],
            "keywords": [
                "regulatory T cells",
                "CAR T",
                "Treg",
                "autologous",
                "cell therapy",
                "hidradenitis suppurativa",
                "autoimmune disease",
                "inflammatory disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "interventionModelDescription": "Sequential escalating dose cohorts",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "SBT777101 Dose Level 1",
                    "type": "EXPERIMENTAL",
                    "description": "Low dose SBT777101",
                    "interventionNames": [
                        "Biological: SBT777101"
                    ]
                },
                {
                    "label": "SBT777101 Dose Level 2",
                    "type": "EXPERIMENTAL",
                    "description": "Mid dose SBT777101",
                    "interventionNames": [
                        "Biological: SBT777101"
                    ]
                },
                {
                    "label": "SBT777101 Dose Level 3",
                    "type": "EXPERIMENTAL",
                    "description": "High dose SBT777101",
                    "interventionNames": [
                        "Biological: SBT777101"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BIOLOGICAL",
                    "name": "SBT777101",
                    "description": "Experimental treatment",
                    "armGroupLabels": [
                        "SBT777101 Dose Level 1",
                        "SBT777101 Dose Level 2",
                        "SBT777101 Dose Level 3"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Incidence, nature, and severity of adverse events [Safety and Tolerability]",
                    "timeFrame": "Day of treatment to end of follow-up period (48 weeks)"
                },
                {
                    "measure": "Incidence and nature of Dose Limiting Toxicities [DLTs]",
                    "timeFrame": "Day of treatment to end of DLT evaluation period (28 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Body mass index (BMI) \u226450 kg/m2, inclusive\n* Diagnosis of clinically active moderate-to-severe HS (Hurley Stage 2 or 3)\n* Total abscess or inflammatory nodule (AN) count of \u22655, affecting at least 2 distinct anatomic regions, with at least 1 accessible AN of adequate size for biopsy (diameter \\> 1 cm)\n* Total draining tunnel (dT) count of \u226420\n* Documented history of inadequate response or intolerance to at least a 3-month course of 1 conventional systemic therapy (e.g., antibiotic) and 1 biologic drug (e.g., adalimumab or secukinumab)\n* Doses of medications for HS must be stable for at least 5 weeks prior to study drug administration\n* Must agree to use highly effective method of contraception for at least 1 year post SBT777101 administration\n\nExclusion Criteria:\n\n* Major surgery within 12 weeks prior to screening or planned within 12 months after dosing\n* History of or current inflammatory or other autoimmune disease\n* Complex presentations of HS\n* Skin disease other than HS that may confound clinical assessments or increase subject risk in the study\n* Uncontrolled concomitant cardiovascular, nervous system, pulmonary, renal, hepatic, endocrine, or gastrointestinal disease\n* Active current infection or history of recurrent infections\n* Active or untreated latent tuberculosis\n* Primary or secondary immunodeficiency",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sabrina Fox-Bosetti, MPH",
                    "role": "CONTACT",
                    "phone": "415-992-6245",
                    "email": "clinicaloperations@sonomabio.com"
                },
                {
                    "name": "Jason Do",
                    "role": "CONTACT",
                    "phone": "415-992-6245",
                    "email": "clinicaloperations@sonomabio.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Joseph Arron, MD PhD",
                    "affiliation": "Sonoma Biotherapeutics, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Brigham and Women's Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02115",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Oliva Gabriel",
                            "role": "CONTACT",
                            "phone": "617-525-8250",
                            "email": "ogabriel@bwh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Irmina Wallander",
                            "role": "CONTACT",
                            "phone": "612-624-5721",
                            "email": "wall0396@umn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "SLUCare Academic Pavillion",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rhonda Lebbing",
                            "role": "CONTACT",
                            "phone": "314-617-3355",
                            "email": "rhonda.lebbing@health.slu.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "The University of Texas MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Stacie Stutte",
                            "role": "CONTACT",
                            "phone": "713-794-1918",
                            "email": "snstutte@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000017497",
                    "term": "Hidradenitis Suppurativa"
                },
                {
                    "id": "D000016575",
                    "term": "Hidradenitis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000013543",
                    "term": "Sweat Gland Diseases"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000017192",
                    "term": "Skin Diseases, Bacterial"
                },
                {
                    "id": "D000001424",
                    "term": "Bacterial Infections"
                },
                {
                    "id": "D000001423",
                    "term": "Bacterial Infections and Mycoses"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                },
                {
                    "id": "D000012874",
                    "term": "Skin Diseases, Infectious"
                },
                {
                    "id": "D000013492",
                    "term": "Suppuration"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M19762",
                    "name": "Hidradenitis Suppurativa",
                    "asFound": "Hidradenitis Suppurativa",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18964",
                    "name": "Hidradenitis",
                    "asFound": "Hidradenitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16323",
                    "name": "Sweat Gland Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M19500",
                    "name": "Skin Diseases, Bacterial",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4722",
                    "name": "Bacterial Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M12136",
                    "name": "Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M4721",
                    "name": "Bacterial Infections and Mycoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M15677",
                    "name": "Skin Diseases, Infectious",
                    "relevance": "LOW"
                },
                {
                    "id": "M16273",
                    "name": "Suppuration",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        }
    },
    "hasResults": false
}